The interaction between cancer cells and microenvironment has a critical role in tumor development and progression. Although microRNAs regulate all the major biological mechanisms, their influence on tumor microenvironment is largely unexplored. Here, we investigate the role of microRNAs in the tumor-supportive capacity of stromal cells. We demonstrated that miR-15 and miR-16 are downregulated in fibroblasts surrounding the prostate tumors of the majority of 23 patients analyzed. Such downregulation of miR-15 and miR-16 in cancer-associated fibroblasts (CAFs) promoted tumor growth and progression through the reduced post-transcriptional repression of Fgf-2 and its receptor Fgfr1, which act on both stromal and tumor cells to enhance cancer cell survival, proliferation and migration. Moreover, reconstitution of miR-15 and miR-16 impaired considerably the tumor-supportive capability of stromal cells in vitro and in vivo. Our data suggest a molecular circuitry in which miR-15 and miR-16 and their correlated targets cooperate to promote tumor expansion and invasiveness through the concurrent activity on stromal and cancer cells, thus providing further support to the development of therapies aimed at reconstituting miR-15 and miR-16 in advanced prostate cancer.
Introduction
The prostate microenvironment is a variegate compartment in which the epithelial cells interact with mesenchymal and inflammatory cells in the presence of extracellular matrix (ECM) and soluble molecules (Bhowmick et al., 2004; De Marzo et al., 2007; Joyce and Pollard, 2009) . The epithelial-stromal interaction has a fundamental role in organ formation and tissue homeostasis. However, during cancer development and progression, the tumor and its microenvironment co-evolve and contribute equally to the acquisition of the metastatic phenotype Cunha et al., 1983; Chung et al., 1989; Tuxhorn et al., 2002; Risbridger and Taylor, 2008; Thiery et al., 2009) . In this context, the stroma acquires tumor-enhancing properties and is defined as 'reactive' (Tuxhorn et al., 2002; Josson et al., 2010) . It has been suggested that a dysfunctional microenvironment can turn a prostatic hypertrophy into a prostate tumor through a process that involves vessel neo-formation and acquisition of androgen insensitivity (Chung et al., 1989; Wu et al., 1994; Hayward et al., 2001; Ao et al., 2007) . Among the cell types cohabitating a reactive stroma, carcinomaassociated fibroblasts (CAFs) are thought to be the main actors, even though it is still unclear if these cells undergo irreversible alterations or epigenetic changes during tumor progression. A complex signaling and many growth factors connect stroma and cancer, including the vascular endothelial growth factor (VEGF-A), bone morphogenetic proteins (BMPs), insulin-like growth factors (IGFs), transforming growth factor-b (TGFb), wingless-type ligand family (WNT), platelet-derived growth factor (PDGF) and fibroblast growth factors (FGFs) (van Moorselaar and Voest, 2002) . In early tumor lesions, aberrant FGF-2 production and expression of its receptor (FGFR1) can alter the epithelial/stromal communication, which ensures the balance between growth and renewal of the epithelial compartment under physiological conditions (KwabiAddo et al., 2004) . Moreover, FGF-2 production by both stromal and tumor cells promotes increased proliferation and metastasis formation in prostate cancer (PCa) (Cronauer et al., 1997; Giri et al., 1999; Yang et al., 2008) . Thus, the FGF-2/FGFR axis is an attractive target for cancer therapy, in terms of both ligand sequestration and receptor inhibition (Smith et al., 2001; He et al., 2003) . In the recent years, considerable attention has been devoted to the study of microRNAs (miRNAs), a family of small non-coding RNAs involved in the regulation of virtually all biological processes (Bartel, 2004; Calin and Croce, 2006) . Many deregulated miRNAs contribute to tumor formation and therefore are potential therapeutic tools or targets against cancer cells. However, the influence of miRNAs on tumor microenvironment and CAFs is still largely unexplored. In a previous report, our group demonstrated that miR-15a (miR-15) and miR-16-1 (miR-16) reduction in tumor cells promotes prostate cancer progression, whereas their reconstitution impairs tumor growth (Bonci et al., 2008) . Here, we extended our study to the prostate stromal compartment, demonstrating a fundamental role of miR-15 and miR-16 in tumor-stroma interaction. Our data offer new insights into the regulation of such cross-talk, thus providing considerable information for the development of innovative therapeutic approaches.
Results miR-15 and miR-16 are downregulated in cancer-associated fibroblasts During the setup of the in situ hybridization for clinical investigations, we noted that miR-15 and miR-16 (miR-15/16) downregulation in prostate cancer tissues was not confined to the tumor cell population. Therefore, we evaluated miR-15/16 levels in prostate stromal compartment through the analysis of 23 non-neoplastic and tumor tissues. A staining score was assigned using a semiquantitative evaluation: negative (score 0), weak (score 1), moderate (score 2) and strong staining (score 3). In the vast majority of tumor samples (17/23 for miR-15 and 18/23 for miR-16), fibroblasts were completely negative or displayed a weak staining (6/23 for miR-15 and 5/23 for miR-16). Non-neoplastic tissueassociated fibroblasts showed variable miRNA expression, ranging from negative (2/23 for miR-15 and 2/23 for miR-16) to weak (8/23 for miR-15 and 10/23 for miR-16), moderate (11/23 for miR-15 and 10/23 for miR-16) or strong staining (2/23 for miR-15 and 1/23 for miR-16). Overall, the majority of the stroma surrounding tumor samples analyzed showed an overt decrease in the levels of both miRNAs as compared with the stroma in the proximity of non-neoplastic gland ( Figure 1a ). The distribution of the scores among tumor and normal samples was significantly different as demonstrated by w 2 test (Po0.00001 for miR-15 tumor vs normal stroma; Po0.0001 for miR-16 tumor vs normal stroma) (Figure 1b) . Thus, there seems to be a considerable correlation between the low levels of miR-15 and miR-16 in the prostate stroma and the vicinity to the neoplastic tissue. In order to obtain a comparison between fibroblasts confining healthy and neoplastic gland from the same patient, we dissociated freshly collected tissue specimens from prostate cancer patients and isolated three couples of cancer and non-neoplastic associated fibroblast lines (CAFs and NAFs, respectively). We evaluated the purity of the cultures testing the expression of specific markers such as fibronectin, vimentin and CD90 by immunofluorescence or cytofluorimetric analysis (Figures 1c and d) . As CAFs are usually recognized by the expression of a-smooth muscle actin (a-SMA) and closely resemble myofibroblasts residing in wound-healing sites, we analyzed them for a-SMA protein expression by western blotting (Figure 1e ). Furthermore, we evaluated by real-time PCR miR-15 and miR-16 levels in the three populations of NAF/CAF, confirming a consistent reduction of miRNA expression in CAFs when compared with NAFs ( Figure 1f) . The clinical features of prostate cancer patients' specimens used for in situ hybridization and CAFs isolation are reported in Supplementary  Table I. miR-15 and miR-16 reconstitution impairs proliferation and supportive capability of cancer-associated fibroblasts In order to evaluate the effect of miR-15 and miR-16 reconstitution on reactive stroma, CAFs were infected with the TWEEN (TW) lentiviral vector, engineered to express both miR-15 and miR-16 genes (miR-15/16) (Bonci et al., 2003 (Bonci et al., , 2008 . We infected CAFs at two different virus doses (1 Â 10 6 and 5 Â 10 5 TU/ml) and evaluated miRNA levels by real-time PCR (Supplementary Figure 1a ). Cancer-associated fibroblasts transduced with the higher dose (1 Â 10 6 TU/ml) of miR-15/ 16 viral supernatant dramatically decelerated their growth, undergoing progressive apoptosis extended in the majority of population 1 week after viral exposure ( Figure 2a In order to test if the miR-15 and miR-16 effect can be reversed, we added miR-15/miR-16 antagomirs to fibroblast cultures transduced with empty or miRNA vectors (5 Â 10 5 TU/ml) and evaluated cell proliferation after 3 days. We found that the specific antagomirs impair exogenous miRNA expression by real-time PCR and that miR15/16-transduced fibroblasts rescued their proliferation rate as compared with the control population ( Supplementary Figures 1f and g ). Thus, miR-15 and miR-16 reconstitution strongly impacts on CAF proliferation and viability in a dose-dependent manner, suggesting that miRNAs could be regulators of genes implicated in proliferation and survival, with possible implications in tumor-stroma cross-talk. In order to investigate the consequent effects of miRNA-reconstituted CAFs on tumor aggressiveness, we tested CAFconditioned medium (CM) on different prostate cancer cell lines. We prepared a 24-h CM from cancerassociated fibroblasts transduced with empty or miR-15/16 vectors at 5 Â 10 5 TU/ml and evaluated their ability to stimulate prostate cancer cell migration and proliferation. As CAFs are able to enhance the aggressiveness of tumor cells, a prostate tumor cell line (RWPE-2) representative of early cancers was tested for its migratory capacity by Boyden chamber assay in the presence of TW or miR-15/16 CM. Non-conditioned culture medium was used as control. Whereas TW CM strongly enhanced the motility capacity of RWPE-2, miR-15/16 CM impaired the pro-migratory ability ( Figure 2c ). As AKT phosphorylation is associated with migration enhancement, in line with the observed effects, western blotting showed a reduction in AKT phosphorylation in cancer cells treated with miR-15/16 CM ( Figure 2d ). Another early prostate cancer cell line, CAHPV10, reduced its migratory capacity in miRNA CM as compared with TW CM (Supplementary Figure   2a) . Likewise, metastatic PC3 cells reduced their motility capacity when maintained for 24 h in miR-15/16 CM, such as demonstrated by scratch-wound assay (Supplementary Figure 2b ) (Kaminski et al., 2006) . Moreover, the metastasis-derived prostate cancer cell line DU145 was maintained in culture with TW or miR-15/16 CM and analyzed after 24 h by bromodeoxyuridine incorporation assay. miR-15/16 CM treatment resulted in reduction of tumor cell proliferation, which correlated with a significant reduction in the percentage of cells in the S-phase of the cell cycle ( Figure 2e ) and with a parallel significant accumulation of cells in G0-G1-phase as shown by propidium iodide staining Control of tumor and microenvironment cross-talk M Musumeci et al ( Figure 2f ). Thus, re-expression of miR-15 and miR-16 in cancer-associated fibroblasts is able to reduce the stroma support capacity in terms of migration and proliferation of early and metastatic tumors, indicating that miR-15 and miR-16 reconstitution in CAFs interferes with the cross-talk between microenvironment and tumor, reducing cancer expansion capability.
FGF-2 and FGFR1 are new targets of miR-15 and miR-16
We subsequently investigated the existence of new miR-15 and miR-16 targets that could be responsible for the tumor-promoting activity of CAFs. We performed a bioinformatic analysis using TargetScan 4.2 and found that the FGF-2/FGFR1 axis was a likely candidate for this effect.
In particular, FGF-2-mediated activation of MEK/ ERK signaling has a critical role in cancer cell proliferation, migration and invasiveness. In line with previous publications (Wernert et al., 2007; Sahni et al., 2008) , we observed that FGF-2 treatment of prostate cancer cells DU145 and PC3 stimulates proliferation and migration, respectively, as shown by cell growth evaluation and scratch-wound assay ( Supplementary  Figures 2c and d) . By luciferase assay, we demonstrated FGF-2 and FGFR1 as new direct targets of miR-15 and miR-16 (Supplementary Figure 2e) . miR-15 and miR-16 reconstitution in cancer-associated fibroblasts confirmed FGF-2 and FGFR1 protein reduction, particularly of all the three FGF-2 isoforms (Figure 3a ). FGF-2 treatment partially rescued the effect of miR-15/16 CM on DU145 cancer cell proliferation (Figure 3b ). Among miR-15 and miR-16 published targets, Ccnd1, Wnt3a and Bcl-2 genes promote prostate cell proliferation, invasion and survival. The analysis of WNT3A, CCND1 and BCL-2 expression by western blotting in TW and miR-15/16 transduced fibroblasts confirmed that the products of these genes are miR-15 and miR-16 targets also in the stromal compartment, underlying the multiple synergic activity of the miRNAs on cancer progression (Figure 3c ). Although we cannot exclude the involvement of additional unknown targets, it is likely that miR-15/16-mediated reduction of fibroblast supportive capacity can be caused by targeting the FGF-2/ FGFR1 axis, WNT3A, CCND1 and BCL-2. Furthermore, western blot analysis showed a reduction of p-AKT and p-ERK in miR-15/16-transduced fibroblasts, as a likely consequence of FGF-2/FGFR1 and WNT3A downregulation (Figure 3c ). Likewise, DU145 treated with miR-15/16 fibroblast CM (miR-15/16 viruses were used at a final concentration of 5 Â 10 5 TU/ml) showed the same decrease in signaling activation (Supplementary Figure 2f) . miR-15 and miR-16 block stromal tumor support in vivo Microenvironment aberrant stimuli can transform nonneoplastic prostate epithelium cells into cancer cells (Hayward et al., 2001; Ao et al., 2007) . Moreover, the cancer-stroma interaction can enhance survival and tumor spreading, leading to metastasis formation (Thiery, 2002; Kalluri and Weinberg, 2009; Polyak and Weinberg, 2009 ). We explored the pro-tumorigenic effects of the cancer-associated stroma in vivo by inoculating a tumor cell line representative of early tumors (RWPE-2) into a permissive site such as the renal capsule of NOD-SCID mice. RWPE-2 cells were infected with a lentiviral vector (TW-Luc) containing the luciferase gene for in vivo imaging. We co-injected RWPE-2 with TW or miR-15/16 transduced fibroblasts (empty or miR-15/16 vectors were used at a final concentration of 5 Â 10 5 TU/ml). Three weeks after injection, we evaluated tumor expansion by in vivo imaging (IVIS system). Empty vector-treated fibroblasts strongly promoted tumor growth by about fourfold as compared with miR-15/16 transduced fibroblasts (Figure 4a ). We therefore sacrificed the mice and analyzed by histology tumor morphology and vascularization. Hematoxylin and eosin (H&E) staining and anti-CD31 immunofluorescence analysis revealed that while co-injection with TW fibroblasts promoted the invasion of RWPE-2 cells into the renal parenchyma coupled with new vessel formation, the co-injection with miR-15/16-transduced fibroblasts was ineffective (Figures 4a and b) . We next analyzed the effect of miR-15/16 reconstitution on a metastasis-derived prostate cancer model. DU145 tumor cells were injected subcutaneously together with TW-or miR-15/16-transduced fibroblasts (1 Â 10 5 fibroblasts and 2 Â 10 5 DU145) obtained with a virus concentration that did not dramatically affect cell survival within the first 3 weeks (5 Â 10 5 TU/ml). As observed for RWPE-2 cells, miR-15/16-transduced fibroblasts severely impaired the tumor growth generated by DU145 cells coinoculated with TW-treated fibroblasts (Figure 4c ). H&E staining showed that the cancer cells mixed with TW fibroblasts functionally recruit and interact with stroma, creating a large front of invasion, whereas miR-15/16-transduced fibroblasts significantly impaired prostate cancer communication, producing a more homogeneous and compact tumor mass (Figure 4d) . Moreover, we observed a considerable reduction of FGF-2 both in the stroma and in the cancer compartment in tumor masses co-injected with miR-15/16-transduced CAFs (Figure 5a ). In addition, at higher magnification we observed some degree of alteration of presumable lymphatic or blood vessels ( Figure 5a ). As FGF signaling also promotes tumor angiogenesis, we extended our study to the evaluation of neovasculature formation in these subcutaneous tumor xenografts. Immunofluorescence analysis on cancer masses demonstrated a strong reduction of CD31 þ vessels at the periphery and inside the inner mass of tumor xenografts obtained with miR15/16-transduced fibroblasts ( Figures  5b and c) , suggesting that the reconstitution of miR-15/ 16 impaired the production of angiogenic factors. To mimic the formation of micro-foci lesions, where the stromal population is more abundant than the tumor compartment, we co-injected DU145 and cancer fibroblast cells in NOD-SCID mice at a final ratio of 1:2 (1 Â 10 5 DU145 and 2 Â 10 5 fibroblasts). Cancer cells co-inoculated with a higher amount of miR-15/16 fibroblasts were unable to form tumors, whereas empty vector fibroblasts mixed with tumor cells strongly Control of tumor and microenvironment cross-talk M Musumeci et al promoted cancer formation (Figure 5d ), further indicating that transduction of miR-15/16 in cancer-associated fibroblasts is able to disrupt microenvironment-tumor cross-talk. As we previously demonstrated that loss of miR-15/16 expression in prostate cancer cells significantly contributes to tumor progression and that their reconstitution caused tumor regression in vitro and in vivo, the proposed study offers a potential dual therapeutic approach by simultaneously blocking tumor and its supportive microenvironment. Non-conditioned culture medium with (10 ng/ml) or without FGF-2 has been used as control (Ctr; FGF-2, 10 ng/ml). Data are mean±s.d. of three independent experiments. (c) To the left, western blotting analysis of WNT3A, CCND1 and BCL-2 in CAFs transduced with TW or miR-15/16. The histograms report the western blotting bands quantification normalized over endogenous control and estimated over TW sample. To the right, signaling transduction evaluation by western blotting of pAKT and pERK in CAFs transduced with TW and miR-15/16; total AKT, ERK, b-tubulin and b-actin were reported as controls. One western blotting representative of three CAF clones is shown. The histograms report the western blotting bands quantification for pERK and pAKT normalized over total ERK and AKT proteins, respectively, and estimated as decrease over TW sample. ). (a) Monitoring of tumor growth 3 weeks after injection by IVIS imaging system. H&E staining of relative masses. One representative image for each group of mice is reported. The histograms show tumor mass expansion when injected into renal capsule and evaluated in three mice for each group in two independent experiments. The tumor area percentage was calculated as fold change over tissue total area. The red arrows mark tumor (T) front of invasion. Phosphate-buffered saline was injected alone into the renal capsule space for surgery control. In order to better visualize and anatomically indicate the renal capsule membrane and space, the yellow line and black arrows were used both in phosphate-buffered saline (PBS) and fibroblast/tumor mixed-population images. 
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Discussion
Prostate cancer cells recruit a functional supportive stroma to create a favorable microenvironment that promotes cancer growth and spreading at primary and metastatic sites (Thiery, 2002; Kalluri and Weinberg, 2009; Polyak and Weinberg, 2009 ). Recent observations indicate that prostate tumor microenvironment is directly implicated in the resistance to therapy (Efstathiou and Logothetis, 2010) . However, the complex interactions between stroma and neoplastic cells are largely unexplored. Here, we demonstrated that miR-15 and miR-16 are often downmodulated in the tumorsurrounding stroma, as a possible result of a conditioning of microenvironment by cancer cells.
As loss of miR-15 and miR-16 has been described as a key event in cancer progression in different tumor types (Cimmino et al., 2005; Bandi et al., 2009; Bhattacharya et al., 2009; Roccaro et al., 2009; Klein et al., 2010) , our data suggest that the tumor suppressor activity of miR-15 and miR-16 is not confined to the cancer cell compartment, but is shared by the tumor microenvironment. MicroRNAs control the expression of multiple targets, offering a great advantage as a possible multiblocking therapeutic approach. miR-15 and miR-16 can target several oncogenes, such as Bcl-2, Ccnd1, Ccne1, Bmi-1 and Wnt family members, which promote cell proliferation, survival and invasion. Moreover, recent data suggest that miR-15 and miR-16 control the expression of VEGF and IL-6, which are able to promote tumor angiogenesis and metastatic homing to the bones, respectively (Iliopoulos et al., 2009; Karaa et al., 2009; Roccaro et al., 2009 ). The tumor microenvironment cross-talk is mediated by many growth factors, including FGF-2. In PCa, stromal FGF-2 level increases in parallel with the acquisition of aggressive properties. Whereas FGF-2 production in early tumors is confined to stromal cells, in advanced prostate cancer FGF-2 is overproduced by tumor cells (Giri et al., 1999; Kwabi-Addo et al., 2004) . Of note, in prostate cancer cell lines, the levels of FGF-2 and FGFR1 have been shown to increase proportionally to the degree of cancer aggressiveness and castration resistance (Nakamoto et al., 1992; Cronauer et al., 1997) . The analysis of tumor specimens has shown that enhanced FGF signaling results in increased proliferation, invasiveness and resistance to therapy in several solid and hematological malignancies (Menzel et al., 1996; Konig et al., 1997; Song et al., 2000; Sezer et al., 2001; Acevedo et al., 2009; Turner et al., 2010) . Moreover, hemi-or homozygous inactivation of Fgf-2 alleles in TRAMP mice with transgenic prostate adenocarcinoma resulted in increased survival by inhibiting progression toward a poorly differentiated and highly metastatic phenotype (Polnaszek et al., 2003) . In our study, we showed that Fgf-2 and Fgfr1 are new targets for miR-15 and miR-16, thus providing further information on the molecular mechanisms through which tumor and stroma influence each other and promote tumor growth and progression. Reconstitution of miR-15 and miR-16 in CAFs severely impaired tumor-supporting capacity, as shown by reduction of proliferation and migration in vitro and impaired tumor expansion in vivo. The FGF-2/FGFR1 axis promotes tumor angiogenesis, triggering the generation of aberrant vessels, which, in turn, may impair drug delivery (Winter et al., 2007) . Our data report a considerable reduction in neo-angiogenesis upon injection in immunocompromised mice of tumor cells mixed with CAFs transduced with miR-15 and miR-16, suggesting a role of their angiogenic targets in this process.
Different approaches have been attempted to inhibit FGFR-mediated signaling, such as developing antibodies to target receptors (He et al., 2003) or smallmolecule inhibitors blocking the catalytic kinase domain (Mohammadi et al., 1997) . Compounds that inhibit FGF signaling, such as suramin, have been found to be able to enhance the antitumor effect of doxorubicin on PCa . The relevance of the FGF-2/ FGFR axis is further corroborated by some phase II studies of BIBF 1120, an orally triple angiokinase (VEGFR, PDGFR, FGFR) inhibitor, which laid the basis for two phase III trials that are currently undergoing in advanced/metastatic lung cancer patients. Our results indicate an innovative molecular tool to inhibit FGF-2/FGFR1 signaling and, more importantly, propose a strategy to obtain a therapeutic targeting of both tumor and stroma compartments. Although the targets of miRNAs may vary depending on the cell type of tissue where they are expressed, we confirmed in CAFs (Shin et al., 2011; Navarro et al., 2011) , a number of articles show that miR-15 and miR-16 act as tumor controller (Aqeilan et al., 2010) . However, our data suggest, as proposed in Figure 5e , that miR-15 and miR-16 may be involved in a molecular loop in which the tumor and microenvironment co-evolve, underlining the importance of miRNA in microenvironment homeostasis and providing a proof-of-concept for innovative therapeutic applications directed against not only the cancer cells but also the tumor microenvironment.
As it is extremely difficult to hypothesize a therapeutic approach with agents targeting exclusively malignant stroma but not tumor cells, miR-15 and miR-16 reconstitution appears as an innovative approach to develop new therapeutics co-targeting simultaneously cancer and its microenvironment. In conclusion, we demonstrated that miR-15 and miR-16 act as tumor suppressors both on tumor and on stromal cells. As miR-15 and miR-16 deregulation are involved in several tumors, the ability to target the microenvironment may enhance their therapeutic efficacy in different malignancies.
Materials and methods
Fibroblast isolation and CM preparation
Fibroblasts were isolated after mechanical and enzymatic dissociation of prostate surgical specimens with 150 mg/ml collagenase II (Gibco, Invitrogen, Carlsbad, CA, USA). The homogenate suspension was put in culture in plates with Dulbecco's modified Eagle's medium (Gibco, Invitrogen) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Fibroblast separation from epithelial cells was obtained by treatment with diluted (1 g/l) trypsin solution for 1-2 min once or twice. This procedure is based on a higher sensitivity of fibroblasts to trypsin. All fibroblast experiments were performed over 2 to 3 weeks after isolation. The frequency of culture isolation is 90% for CAFs and 10% for NAFs. Tissues were obtained from radical prostatectomy at the Department of Urology, S. Giovanni Bosco Hospital of Turin, Italy. Benign and neoplastic tissue specimens were taken from the prostate base in the transition zone and the suspicious areas in the peripheral zone, respectively. The tumoral or non-tumoral nature of each sample was confirmed by histopathological examination. All samples were collected with the informed consent of the patients and clinical features are reported in Supplementary Table I. CM was prepared by cultivating human prostate cancer fibroblasts infected with TW or miR-15/16 at 5 Â 10 5 TU/ml in RPMI supplemented with 0.5% FBS or in keratinocyte serumfree medium for 24 h; CM was then collected, filtered with 0.22 mm filters and kept at À20 1C until use. CMs were prepared after 48 h from virus infection. For CM preparation fibroblasts after viral exposure were extensively washed with phosphate-buffered saline and cultivation medium was tested on a highly infectable cell line, Hela, and analyzed for EGFP expression to exclude viral particle residues. In all experiments CM was then diluted 1:2 with fresh medium. The control medium was RPMI 0.5% FBS or keratinocyte serum-free medium. To examine the effects of fibroblast CM on cancer cell proliferation, DU145 cells were incubated for 24 h with CM from CAFs infected with TW or miR-15/16. Cells cultivated in RPMI medium with 0.5% FBS were used as control. Cell growth was evaluated by Trypan Blue staining.
Target screening. In this study, we used a publicly available search engine for target prediction: TargetScan, http://genes. mit.edu/targetscan (Lewis et al., 2003 (Lewis et al., , 2005 Bartel, 2004) .
In situ hybridization, immunohistochemistry Locked nucleic acid-modified probes biotinylated at the 5 0 end (Exiqon, Vedbaek, Denmark) were used to detect the in situ hybridization signal for miR-15 and miR-16 on formalin-fixed, paraffin-embedded prostate tissues. In situ hybridization was performed as previously described in Bonci et al. (2008) and analysis of staining score in stroma surrounding neoplastic and non-neoplastic prostate epithelium was performed by an experienced pathologist. For analysis of in vivo experiments, tumor masses, both obtained from mice injected subcutaneously and into subrenal capsule, were snap-frozen in OCT and stored at À80 1C. Cryostatic sections were stained with hematoxylin and eosin, dehydrated and mounted with xylene. For FGF-2 immunohistochemistry detection, frozen sections (3-5 mm), obtained using a cryomicrotome (Kriostat 1720 MGW Leitz, Melville, NY, USA), were fixed in paraformaldehyde 4% at room temperature for 15 min; endogenous peroxidase activities were blocked using 0.03% hydrogen peroxide for 15 min; sections were incubated at 4 1C overnight with anti-FGF-2 (1:100; 610072; BD Pharmingen, San Jose, CA, USA). Sections were then processed using avidin-biotinperoxidase complex (ULTRATEK HRP SCY tek UCS Diagnostic s.r.l., Morlupo, RM, Italy), counterstained with hematoxylin and permanently mounted under a coverslip with DPX (Sigma, St Louis, MO, USA).
For CD31 immunofluorescence analysis, cryostatic sections were fixed with paraformaldehyde and then blocked with 5% serum in phosphate-buffered saline containing 1% bovine serum albumin and 0.1% Triton X-100. After 1 h of incubation at room temperature, sections were stained overnight at 4 1C with phycoerythrin mouse anti-CD31 (1:50; 553373; BD Pharmingen). Cell nuclei were stained using 4 0 ,6-diamidino-2-phenylindole. Fluorescent signals from a single optical section were acquired by a three-laser confocal microscope (Olympus FV1000, Segrate, MI, Italy).
In vivo models Six-to eight-week-old male NOD-SCID mice were purchased from Charles River Laboratories (Calco, LC, Italy) and housed in groups of four in isolated ventilated cages; food and water were provided ad libitum. All animal procedures were performed according to the protocol approved by the Istituto Superiore di Sanita`Animal Care Committee. A total of 100 ml of cell suspension in matrigel (1:1, vol/vol) was subcutaneously injected into the flank of mice. CAFs were irradiated with 10 cGy using a cesium source before in vivo inoculation. For the subrenal capsule (SRC) injection animals were anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg). Under sterile conditions, a skin incision of approximately 1 cm was made along the dorsal midline of an anesthetized mouse. With the mouse lying on its side, a body wall incision was then made slightly shorter than the long axis of the kidney. The left kidney was slipped out of the body by applying pressure on both sides of the organ using the forelimb and thumb. Injection of a mixture of cells resuspended in 15 ml of matrigel was administered with a 29-G needle in the subcapsular space of the kidney, taking care not to damage the parenchyma. Phosphate-buffered saline was injected as surgery control. The kidney was then gently eased back into the peritoneal space; the body wall incision was closed using a 4/0 absorbable suture, while the skin incision was closed with surgical staples. Approximately 1 ml of saline solution was administered subcutaneously immediately after surgery. For in vivo imaging analysis, mice were injected intraperitoneally with 150 mg/kg D-luciferin (Caliper Life Sciences, Tremblay en France, France) 10 min before imaging and then were sedated with 20 mg/kg valium. A cryogenically cooled imaging system (IVIS 100 Imaging System, Xenogen, Tremblay en France, France) was used for data acquisition. Whole animal imaging was used to monitor tumor growth; signal intensities were quantified as the sum of all detected photons.
Statistical analysis. Data are presented as the mean þ s.d. Results of bromodeoxyuridine, luciferase assays, propidium iodide staining and in vivo experiments were analyzed by twoway analysis of variance test. In situ hybridization data were analyzed with w 2 -test. The immunofluorescence and immunohistochemistry figures were quantified by the KS300 (Carl Zeiss, Jena, Germany) image analysis software and expressed as the percentage of positive area over the total tissue area.
For additional information and methods see Supplementary files.
